Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
14 (5%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1199 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1204 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1454 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2019-12-09 | 2025-01-23 | 100550 |
| TEVA-PAROXETINE | 20MG | TABLET | Resolved | 2019-12-09 | 2025-01-23 | 100553 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2019-12-09 | 2020-02-21 | 100556 |
| TEVA-PAROXETINE | 10MG | TABLET | Resolved | 2019-12-09 | 2025-03-20 | 100559 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2019-12-09 | 2020-02-21 | 100562 |
| TEVA-PAROXETINE | 30MG | TABLET | Resolved | 2019-12-09 | 2020-02-21 | 100565 |
| TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110761 |
| TEVA-PERINDOPRIL | 8MG | TABLET | Resolved | 2020-07-09 | 2020-08-21 | 119883 |
| TEVA-PERINDOPRIL | 8MG | TABLET | Resolved | 2022-03-04 | 2022-05-19 | 156073 |
| TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2022-08-18 | 2022-10-01 | 167215 |
| TEVA-PERINDOPRIL | 4MG | TABLET | Resolved | 2025-05-15 | 2025-06-13 | 257538 |
| TEVA-PERINDOPRIL | 2MG | TABLET | Resolved | 2025-10-10 | 2025-11-06 | 269249 |
| TEVA-PERINDOPRIL | 8MG | TABLET | Actual shortage | 2025-11-27 | 2025-12-11 | 272760 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 4MG 1.25MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110703 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 8MG 2.5MG | TABLET | Resolved | 2020-08-13 | 2020-10-22 | 122211 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2021-06-03 | 2021-06-10 | 140396 |
| TEVA-PERINDOPRIL/INDAPAMIDE | 1.25MG 4MG | TABLET | Resolved | 2022-01-20 | 2022-01-28 | 153162 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| TEVA-FUROSEMIDE | 40MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14042 |
| TEVA-GLYBURIDE | 2.5MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258547 |
| TEVA-HALOPERIDOL | 20MG | TABLET | Discontinued | 2019-10-25 | 2019-10-26 | 97270 |
| TEVA-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258383 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
| TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106158 |
| TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106161 |
| TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106164 |
| TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106167 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| TEVA-IRBESARTAN | 150MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260527 |
| TEVA-IRBESARTAN | 300MG | TABLET TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260546 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231577 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231580 |
| TEVA-IRBESARTAN HCTZ | 150MG 12.5MG | TABLET | Discontinued | 2025-06-17 | 2025-06-17 | 260549 |
| TEVA-LAMIVUDINE/ZIDOVUDINE | 300MG 150MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104260 |